RGEN
Repligen Corporation
Medical Instruments & Supplies · Healthcare · United States
188.64
close · 2026-10-29
value
7
cheaper than peers7
quality
45
stronger fundamentals45
ranked against
Medical Instruments & Supplies
value
quality
33 peerswide variation
Value inputs
| measure | company | vs peers |
| price to book | 5.11× | 27 |
| forward P/E | 71.26× | 20 |
| price to sales | 14.22× | 11 |
| EV to EBITDA | 69.73× | 10 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| revenue growth | 11.9% | 61 |
| debt to equity | 32.7% | 52 |
| operating margin | 9.3% | 44 |
| return on equity | 2.0% | 42 |
4 of 4 measures available
Facts
| market cap | $12B |
| free cash flow | $113.4M |
| employees | 2,000 |
| first trade | 1986-04-29 |
| next earnings | 2026-10-27 |
| fundamentals updated | 2026-10-27 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | 0.86 | -0.46 | 0.74 | 3.24 |
| free cash flow | $91.7M | $142.5M | $74.9M | $38.7M |
| net income | $48.9M | -$25.5M | $35.6M | $186.0M |
| revenue | $738.3M | $634.4M | $632.4M | $801.5M |
| unusual items | $41.2M | $32.6M | $42.0M | $35.7M |